Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
How Regeneron Pharmaceuticals, Sanofi, And Amgen Will Weather The Inevitable Price Wars
Seeking Alpha
Wed, 02/4/15 - 01:18 pm
Regeneron
Sanofi
Amgen
drug pricing
This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market
Motley Fool
Mon, 02/2/15 - 10:08 am
Ophthotech
Novartis
Regeneron
Fovista
Roche
Avastin
Eylea
Lucentis
wet age-related macular degeneration
Drugmakers receive mysterious invites to White House
CNBC
Wed, 01/28/15 - 08:00 pm
R&D
personalized medicine
Obama
Merck
Regeneron
Vertex Pharmaceuticals
Sanofi and Regeneron Gain Edge on Amgen in Cholesterol Drug Race
Bloomberg
Mon, 01/26/15 - 08:08 am
Sanofi
Regeneron
Amgen
alirocumab
evolocumab
PCSK9 inhibitors
Benefits firms shouldn't play drug favorites: CEO
CNBC
Tue, 01/20/15 - 09:12 am
PBMs
Regeneron
Leonard Schleifer
Express Scripts
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
After Roiling Hepatitis Market, Express Scripts Turns to Cholesterol
Bloomberg
Wed, 01/14/15 - 10:08 am
hepatitis C
Express Scripts
Regeneron
Amgen
PCSK9 inhibitor
Express Scripts CEO: Amgen, Regeneron Among Targets for Drug Discounting
TheStreet.com
Tue, 01/13/15 - 04:46 pm
Express Scripts
drug pricing
Amgen
Regeneron
Sanofi, Regeneron cholesterol drug also effective in monthly doses
Yahoo/Reuters
Fri, 01/9/15 - 08:03 am
Sanofi
Regeneron
alirocumab
5 Potential Blockbuster Drugs Set To Launch In 2015
Investors.com
Thu, 01/8/15 - 08:15 am
Amgen
Regeneron
evolocumab
alirocumab
Alexion
asfotase alfa
Novartis
LCZ696
Pfizer
palbociclib
Where Are They Now? A Look Back at the Best & Worst Biotech CEOs
TheStreet.com
Tue, 12/16/14 - 12:06 pm
biotech
Vertex Pharmaceuticals
Myriad Genetics
Dendreon
Celgene
Regeneron
FDA to Review Eylea for Diabetic Retinopathy
Monthly Prescribing Reference
Mon, 12/1/14 - 10:36 am
FDA
Eylea
diabetic retinopathy
Regeneron
Regeneron drug highly effective for those who can't take statins: study
Reuters
Tue, 11/18/14 - 03:49 pm
Regeneron
statins
Sanofi
alirocumab
Long-Awaited Study Boosts Merck, Could Be Good News for Regeneron, Amgen
Barron's
Mon, 11/17/14 - 04:03 pm
Merck
Vytorin
Amgen
Regeneron
Sanofi's dual-action biotech asthma drug performs well in test
Yahoo/Reuters
Tue, 11/11/14 - 08:57 am
Sanofi
asthma
dupilumab
Regeneron
Eyeing Eylea's heirs, Regeneron spends more and more on R&D
Fierce Biotech
Wed, 11/5/14 - 08:15 am
Eylea
Regeneron
R&D
Four Biotechs Lead Health Care Stocks In Big Cap 20
Investors.com
Tue, 10/28/14 - 08:44 am
Alexion
Amgen
Celgene
Regeneron
Biogen Leads 5 Top Biotech Stocks As Earnings Loom
Investors.com
Tue, 10/21/14 - 09:55 pm
Biogen Idec
earnings
Celgene
Alexion
Regeneron
Gilead Sciences
Sanofi, Regeneron start Phase 3 trial of dupilumab in eczema
Yahoo/Reuters
Mon, 10/20/14 - 08:17 am
Sanofi
Regeneron
dupilumab
eczema
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement
Yahoo
Fri, 10/17/14 - 09:56 am
Amgen
Sanofi
Regeneron
patents
alirocumab
monoclonal antibodies
evolocumab
Pages
« first
‹ previous
…
31
32
33
34
35
36
37
38
39
…
next ›
last »